Literature DB >> 16206183

In vivo comparison of the reinforcing and dopamine transporter effects of local anesthetics in rhesus monkeys.

Kristin M Wilcox1, Heather L Kimmel, Kimberly P Lindsey, John R Votaw, Mark M Goodman, Leonard L Howell.   

Abstract

Dopaminergic mechanisms are thought to play a central role in the reinforcing effects of cocaine. Similar to cocaine, other local anesthetics bind to the dopamine transporter (DAT) and inhibit DA uptake in rodent and monkey brain. Additionally, local anesthetics are self-administered in rhesus monkeys, indicative of abuse liability. The present study examined the reinforcing and DAT effects of the local anesthetics dimethocaine, procaine and cocaine using in vivo techniques. Monkeys were trained to respond under a second-order schedule for i.v. cocaine administration (0.10 or 0.30 mg/kg/infusion). When responding was stable, dimethocaine (0.030-1.7 mg/kg/ infusion) or procaine (0.10-10 mg/kg/ infusion) was substituted for the cocaine training dose. Dimethocaine administration produced higher response rates compared with that of procaine, and was a more potent reinforcer. Drug effects on behavior were related to DAT occupancy in monkey striatum during neuroimaging with positron emission tomography (PET). DAT occupancy was determined by displacement of 8-(2-[(18)F]fluroethyl)2beta-carbomethoxy-3beta-(4-chlorophenyl)nortropane (FECNT). DAT occupancy was between 66 and 82% and <10-41% for doses of dimethocaine and procaine that maintained maximum response rates, respectively. Finally, in vivo microdialysis in awake subjects determined drug-induced changes in extracellular DA in the caudate nucleus. There was close correspondence between peak increases in DA and DAT occupancy. Overall, reinforcing effects were consistent with DAT effects determined with in vivo techniques. The results further support a role for the DAT in the abuse liability of local anesthetics. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16206183     DOI: 10.1002/syn.20199

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  18 in total

1.  The neuropharmacology of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine ("ecstasy"): a concurrent microdialysis and plasma analysis study.

Authors:  K S Murnane; H L Kimmel; K C Rice; L L Howell
Journal:  Horm Behav       Date:  2011-12-14       Impact factor: 3.587

2.  Faster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeys.

Authors:  Heather L Kimmel; Joann A O'Connor; F Ivy Carroll; Leonard L Howell
Journal:  Pharmacol Biochem Behav       Date:  2006-12-20       Impact factor: 3.533

3.  Neural response to lidocaine in healthy subjects.

Authors:  Bryon Adinoff; Michael D Devous; Donald C Cooper; Susan E Best; Thomas S Harris; Mark J Williams
Journal:  Psychiatry Res       Date:  2009-06-28       Impact factor: 3.222

4.  Nonhuman primate positron emission tomography neuroimaging in drug abuse research.

Authors:  Leonard Lee Howell; Kevin Sean Murnane
Journal:  J Pharmacol Exp Ther       Date:  2011-02-11       Impact factor: 4.030

5.  Dopamine transporter-related effects of modafinil in rhesus monkeys.

Authors:  Monica L Andersen; Eileen Kessler; Kevin S Murnane; Jessica C McClung; Sergio Tufik; Leonard L Howell
Journal:  Psychopharmacology (Berl)       Date:  2010-04-13       Impact factor: 4.530

6.  Relative reinforcing effects of second-generation synthetic cathinones: Acquisition of self-administration and fixed ratio dose-response curves in rats.

Authors:  Brenda M Gannon; Kayla I Galindo; Melson P Mesmin; Agnieszka Sulima; Kenner C Rice; Gregory T Collins
Journal:  Neuropharmacology       Date:  2017-08-12       Impact factor: 5.250

Review 7.  Neuroimaging and drug taking in primates.

Authors:  Kevin S Murnane; Leonard L Howell
Journal:  Psychopharmacology (Berl)       Date:  2011-03-01       Impact factor: 4.530

Review 8.  Monoamine transporter inhibitors and substrates as treatments for stimulant abuse.

Authors:  Leonard L Howell; S Stevens Negus
Journal:  Adv Pharmacol       Date:  2014

Review 9.  Nonhuman primate neuroimaging and the neurobiology of psychostimulant addiction.

Authors:  Leonard L Howell; Kevin S Murnane
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 10.  Nonhuman primate neuroimaging and cocaine medication development.

Authors:  Leonard L Howell
Journal:  Exp Clin Psychopharmacol       Date:  2008-12       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.